James leads one of the region’s most advanced nuclear theranostics programs, using molecular imaging not only to diagnose cancer, but to guide and deliver treatment. This conversation stays grounded in practice: how patients are selected, how imaging drives decisions, and how programs actually get built. In this episode of Rethink Imaging, Chris St. John sits down with Dr. James Cassuto to unpack what theranostics looks like when it’s done right, inside a real health system, serving real patients.